Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paritha I Arumugam

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Hematology. American Society of Hematology. Education Program|November 24, 2005
Gene Therapy for beta-thalassemiaPunam Malik, Paritha I Arumugam
Annals of the New York Academy of Sciences|December 13, 2005
Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulatorPunam Malik, Paritha I Arumugam, Jing-Kuan Yee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 12, 2007
Improved human beta-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator elementParitha I Arumugam, Jessica Scholes, Natalya Perelman, et al.
Plos One|September 12, 2009
The 3' region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activityParitha I Arumugam, Fabrizia Urbinati, Chinavenmeni S Velu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2009
Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control regionParitha I Arumugam, Tomoyasu Higashimoto, Fabrizia Urbinati, et al.
Molecular Therapy. Methods & Clinical Development|June 9, 2015
Pigtailed macaques as a model to study long-term safety of lentivirus vector-mediated gene therapy for hemoglobinopathiesHans-Peter Kiem, Paritha I Arumugam, Christopher R Burtner, et al.
Blood|August 20, 2015
Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease miceParitha I Arumugam, Eric S Mullins, Shiva Kumar Shanmukhappa, et al.
Blood Advances|May 12, 2019
Elimination of the fibrinogen integrin α<sub>M</sub>β<sub>2</sub>-binding motif improves renal pathology in mice with sickle cell anemiaMd Nasimuzzaman, Paritha I Arumugam, Eric S Mullins, et al.
The Journal of Clinical Investigation|December 23, 2015
Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13Marthe-Sandrine Eiymo Mwa Mpollo, Eric B Brandt, Shiva Kumar Shanmukhappa, et al.
Nature Medicine|May 26, 2025
Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trialMichael Grimley, Stella M Davies, Archana Shrestha, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Hematology. American Society of Hematology. Education Program|November 24, 2005
Gene Therapy for beta-thalassemiaPunam Malik, Paritha I Arumugam
Annals of the New York Academy of Sciences|December 13, 2005
Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulatorPunam Malik, Paritha I Arumugam, Jing-Kuan Yee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 12, 2007
Improved human beta-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator elementParitha I Arumugam, Jessica Scholes, Natalya Perelman, et al.
Plos One|September 12, 2009
The 3' region of the chicken hypersensitive site-4 insulator has properties similar to its core and is required for full insulator activityParitha I Arumugam, Fabrizia Urbinati, Chinavenmeni S Velu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 27, 2009
Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control regionParitha I Arumugam, Tomoyasu Higashimoto, Fabrizia Urbinati, et al.
Molecular Therapy. Methods & Clinical Development|June 9, 2015
Pigtailed macaques as a model to study long-term safety of lentivirus vector-mediated gene therapy for hemoglobinopathiesHans-Peter Kiem, Paritha I Arumugam, Christopher R Burtner, et al.
Blood|August 20, 2015
Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease miceParitha I Arumugam, Eric S Mullins, Shiva Kumar Shanmukhappa, et al.
Blood Advances|May 12, 2019
Elimination of the fibrinogen integrin α<sub>M</sub>β<sub>2</sub>-binding motif improves renal pathology in mice with sickle cell anemiaMd Nasimuzzaman, Paritha I Arumugam, Eric S Mullins, et al.
The Journal of Clinical Investigation|December 23, 2015
Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13Marthe-Sandrine Eiymo Mwa Mpollo, Eric B Brandt, Shiva Kumar Shanmukhappa, et al.
Nature Medicine|May 26, 2025
Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trialMichael Grimley, Stella M Davies, Archana Shrestha, et al.
Pageof 1